Cargando…
Incidence of Long COVID and Impact of Medications on the Risk of Developing Long COVID in a Nationwide Cohort of IBD Patients
Autores principales: | Khan, Nabeel, Mahmud, Nadim, Patel, Manthankumar, Sundararajan, Ramaswamy, Reinisch, Walter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
W.B. Saunders for the American Gastroenterological Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841334/ https://www.ncbi.nlm.nih.gov/pubmed/36566815 http://dx.doi.org/10.1016/j.cgh.2022.12.017 |
Ejemplares similares
-
Adverse Events Related to SARS-CoV-2 Vaccine in a Nationwide Cohort of Patients With Inflammatory Bowel Disease
por: Mahmud, Nadim, et al.
Publicado: (2022) -
Impact of Biologics on SARS-COV-2 Disease Course When Infused Within 2 Weeks of Acquiring the Infection Among IBD Patients
por: Khan, Nabeel, et al.
Publicado: (2023) -
Risk factors for SARS-CoV-2 infection and course of COVID-19 disease in patients with IBD in the Veterans Affair Healthcare System
por: Khan, Nabeel, et al.
Publicado: (2021) -
COVID-19 Vaccine Effectiveness Against the Omicron Variant in a Veterans Affairs Cohort of Patients With Inflammatory Bowel Disease
por: Khan, Nabeel, et al.
Publicado: (2023) -
Effectiveness of SARS-CoV-2 Vaccination in a Veterans Affairs Cohort of Patients With Inflammatory Bowel Disease With Diverse Exposure to Immunosuppressive Medications
por: Khan, Nabeel, et al.
Publicado: (2021)